Third, whereas the 5xFAD×Tg30×APP-/- line provides a powerful AD model for determining the effects of murine APP deletion on both amyloid and tau pathologies, it is based on a highly specific transgenic context, including mutant human APP, PS1, and tau overexpression. This evidence concerns the gene MAPT and Alzheimer disease.